BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 32157621)

  • 1. Importance of long-term follow-up after endoscopic management for upper tract urothelial carcinoma and factors leading to surgical management.
    Mohapatra A; Strope SA; Liu N; Winer A; Benfante NE; Coleman JA; Vetter J; Murray KS
    Int Urol Nephrol; 2020 Aug; 52(8):1465-1469. PubMed ID: 32157621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Upper Tract Urothelial Carcinoma Diagnostic Modality on Intravesical Recurrence after Radical Nephroureterectomy: A Single Institution Series and Updated Meta-Analysis.
    Sharma V; Miest TS; Juvet TS; Toussi A; Packiam V; Chamie K; Matin SF; Boorjian SA; Thompson RH; Frank I; Tollefson MK; Potretzke AM
    J Urol; 2021 Sep; 206(3):558-567. PubMed ID: 33908802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic versus laparoscopic management of noninvasive upper tract urothelial carcinoma: 20-year single center experience.
    Cutress ML; Stewart GD; Tudor EC; Egong EA; Wells-Cole S; Phipps S; Thomas BG; Riddick AC; McNeill SA; Tolley DA
    J Urol; 2013 Jun; 189(6):2054-60. PubMed ID: 23228378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of diagnostic ureteroscopy before radical nephroureterectomy on intravesical recurrence in patients with upper tract urothelial cancer.
    Chung Y; Lee DH; Lee M; Kim H; Lee S; Hong SK; Byun SS; Lee SE; Oh JJ
    Investig Clin Urol; 2020 Mar; 61(2):158-165. PubMed ID: 32158966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment utilization and overall survival in patients receiving radical nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma: evaluation of updated treatment guidelines.
    Upfill-Brown A; Lenis AT; Faiena I; Salmasi AH; Johnson DC; Pooli A; Drakaki A; Gollapudi K; Blumberg J; Pantuck AJ; Chamie K
    World J Urol; 2019 Jun; 37(6):1157-1164. PubMed ID: 30267197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effect of Diagnostic Ureterorenoscopy on Intravesical Recurrence in Patients Undergoing Nephroureterectomy for Primary Upper Tract Urinary Carcinoma.
    İzol V; Deger M; Ozden E; Bolat D; Argun B; Baltaci S; Celik O; Akgul HM; Tinay İ; Bayazit Y;
    Urol Int; 2021; 105(3-4):291-297. PubMed ID: 33264798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel.
    Seisen T; Peyronnet B; Dominguez-Escrig JL; Bruins HM; Yuan CY; Babjuk M; Böhle A; Burger M; Compérat EM; Cowan NC; Kaasinen E; Palou J; van Rhijn BW; Sylvester RJ; Zigeuner R; Shariat SF; Rouprêt M
    Eur Urol; 2016 Dec; 70(6):1052-1068. PubMed ID: 27477528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ureteroscopic and extirpative treatment of upper urinary tract urothelial carcinoma: a 15-year comprehensive review of 160 consecutive patients.
    Grasso M; Fishman AI; Cohen J; Alexander B
    BJU Int; 2012 Dec; 110(11):1618-26. PubMed ID: 22458598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience.
    Cutress ML; Stewart GD; Wells-Cole S; Phipps S; Thomas BG; Tolley DA
    BJU Int; 2012 Dec; 110(11):1608-17. PubMed ID: 22564677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Factors for Intravesical Recurrence after Minimally Invasive Nephroureterectomy for Upper Tract Urothelial Cancer (ROBUUST Collaboration).
    Katims AB; Say R; Derweesh I; Uzzo R; Minervini A; Wu Z; Abdollah F; Sundaram C; Ferro M; Rha K; Mottrie A; Rosiello G; Simone G; Eun DD; Reese A; Kidd LC; Porter J; Bhattu AS; Gonzalgo ML; Margulis V; Marcus J; Danno A; Meagher M; Tellini R; Mari A; Veccia A; Ghoreifi A; Autorino R; Djaladat H; Mehrazin R
    J Urol; 2021 Sep; 206(3):568-576. PubMed ID: 33881931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of delay to nephroureterectomy for patients undergoing ureteroscopic biopsy and laser tumor ablation of upper tract transitional cell carcinoma.
    Boorjian S; Ng C; Munver R; Palese MA; Vaughan ED; Sosa RE; Del Pizzo JJ; Scherr DS
    Urology; 2005 Aug; 66(2):283-7. PubMed ID: 16098357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic ureteroscopy prior to nephroureterectomy for urothelial carcinoma is associated with a high risk of bladder recurrence despite technical precautions to avoid tumor spillage.
    Baboudjian M; Al-Balushi K; Michel F; Lannes F; Akiki A; Gaillet S; Delaporte V; Ragni E; Toledano H; Karsenty G; Rossi D; Bastide C; Lechevallier E; Boissier R
    World J Urol; 2020 Jan; 38(1):159-165. PubMed ID: 30993427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes of nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma.
    Gadzinski AJ; Roberts WW; Faerber GJ; Wolf JS
    J Urol; 2010 Jun; 183(6):2148-53. PubMed ID: 20399468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The oncologic impact of a delay between diagnosis and radical nephroureterectomy due to diagnostic ureteroscopy in upper urinary tract urothelial carcinomas: results from a large collaborative database.
    Nison L; Rouprêt M; Bozzini G; Ouzzane A; Audenet F; Pignot G; Ruffion A; Cornu JN; Hurel S; Valeri A; Roumiguie M; Polguer T; Hoarau N; Mérigot de Treigny O; Xylinas E; Matte A; Droupy S; Fais PO; Descazeaud A; Colin P;
    World J Urol; 2013 Feb; 31(1):69-76. PubMed ID: 23070533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative Pyuria Predicts for Intravesical Recurrence in Patients With Urothelial Carcinoma of the Upper Urinary Tract After Radical Nephroureterectomy Without a History of Bladder Cancer.
    Sato G; Yoshida T; Yanishi M; Saito R; Murota T; Kawa G; Kinoshita H; Matsuda T
    Clin Genitourin Cancer; 2020 Apr; 18(2):e167-e173. PubMed ID: 31635939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bladder mapping of tumour recurrence after radical nephroureterectomy for upper tract urothelial carcinoma and its influence on oncological outcomes.
    Belhadj Y; Grande P; Seisen T; Gobert A; Gomez FD; Cussenot O; Roupret M
    BJU Int; 2019 Apr; 123(4):618-623. PubMed ID: 30548115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Ureteroscopy Prior to Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma Increased the Risk of Intravesical Recurrence.
    Tan P; Xie N; Yang L; Liu L; Tang Z; Wei Q
    Urol Int; 2018; 100(1):92-99. PubMed ID: 29224014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma.
    Rouprêt M; Hupertan V; Traxer O; Loison G; Chartier-Kastler E; Conort P; Bitker MO; Gattegno B; Richard F; Cussenot O
    Urology; 2006 Jun; 67(6):1181-7. PubMed ID: 16765178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma.
    Brien JC; Shariat SF; Herman MP; Ng CK; Scherr DS; Scoll B; Uzzo RG; Wille M; Eggener SE; Terrell JD; Lucas SM; Lotan Y; Boorjian SA; Raman JD
    J Urol; 2010 Jul; 184(1):69-73. PubMed ID: 20478585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic role of the preoperative serum albumin : globulin ratio after radical nephroureterectomy for upper tract urothelial carcinoma.
    Otsuka M; Kamasako T; Uemura T; Takeshita N; Shinozaki T; Kobayashi M; Komaru A; Fukasawa S
    Int J Urol; 2018 Oct; 25(10):871-878. PubMed ID: 30103271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.